John Buckingham was one of seven investors featured in Bottom Line Personal’s article titled “The Shrewdest Money Moves You Can Make In 2017.” John believes that under the Trump administration, U.S. economic growth will be stimulated. He always favors dividend-paying stocks and thinks that some drug companies have recently become undervalued and utilities are currently overvalued (as of January 2017). One of his current favorites is Amgen.
Click here to read the article.
